Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor

Alexis Leonard, MD, Naoya Uchida, MD, David F. Stroncek, MD, Sandhya R. Panch, MDMPH, Kamille West, Eoghan George Molloy, MD, Tom Hughes, Pharm.D., Sara Hauffe, RN, Tiffani Taylor, Courtney D. Fitzhugh, MD, Jane S. Hankins, MD MS, Megan Wilson, MSW, CCRP, Akshay Sharma, MBBS, Shengdar Q. Tsai, PhD, Mitchell J. Weiss, MD, PhD, Matthew Hsieh, MD, John F. Tisdale, MD

Blood (2019) 134 (Supplement_1): 1964.

https://doi.org/10.1182/blood-2019-126091

Published: 2019

Journal Articles

PD-1 Is Not a Reliable Marker of Impending Relapse after Allogeneic Stem Cell Transplantation

Prachi Jain, MD, Xin Tian, PhD, Jinguo Chen, MD, Caroline R Cantilena, Christian Bradley, Reema Panjwani, BS, Keyvan Keyvanfar, Fariba Chinian, MS, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Sara Hauffe, RN, Minoo Battiwalla, MD, A John Barrett, MD, Sawa Ito, MD

Blood (2017) 130 (Supplement 1): 4509.

https://doi.org/10.1182/blood.V130.Suppl_1.4509.4509

Published: 2017

Journal Articles

IFN-γ Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells

Reema Panjwani, BS, Stefan Cordes, MD PhD, Zerick Terrell Dunbar, BS, MS, Jinguo Chen, MD, Prachi Jain, MD, Fariba Chinian, MS, Sara Hauffe, RN, Eleftheria Koklanaris, RN, Jeanine Superata, RN, Rongye Shi, MD, Huizhi Zhou, David Stroncek, MD, Nan Zhang, PhD, Sarah Davies, BS, Minoo Battiwalla, MD, Austin John Barrett, MD FRCP, FRCPath, Sawa Ito, MD

Blood (2017) 130 (Supplement 1): 4472.

https://doi.org/10.1182/blood.V130.Suppl_1.4472.4472

Published: 2017

Journal Articles

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Natasha A Jain, MD, Prathima Anandi, MD, Upneet Chawla, BS, MD, Sawa Ito, MD PhD, Debbie Draper, RN, Eleftheria Koklanaris, RN, Sara Hauffe, RN, Jeanine Superata, RN, Robert Q. Le, MD PhD, David Stroncek, MD, Pawel Muranski, MD, Minoo Battiwalla, MD MS, John Barrett, MD

Blood (2016) 128 (22): 4596.

https://doi.org/10.1182/blood.V128.22.4596.4596

Published: 2016

Journal Articles

Safety and Feasibility of Ultra-Low Dose IL-2 As Graft Versus Host Disease Prophylaxis in Haplo-Identical Stem Cell Transplantation- a Proof of Concept Pilot Study

Sawa Ito, MD PhD, Prachi Jain, MD, Caroline R Cantilena, BA, Prathima Anandi, MD, Kit Lu, MD, Fariba Chinian, Debbie Draper, RN, Libby Koklanaris, RN, Sara Hauffe, RN, Jeanine Superata, RN, Andra Krauze, MD, David Stroncek, MD, Adams Sharon, MT, Thomas E. Hughes, PharmD, Pawel Muranski, MD, Minoo Battiwalla, MDMS, John Barrett, MD

Blood (2016) 128 (22): 386.

https://doi.org/10.1182/blood.V128.22.386.386

Published: 2016

NARROW

Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor

PD-1 Is Not a Reliable Marker of Impending Relapse after Allogeneic Stem Cell Transplantation

IFN-γ Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Safety and Feasibility of Ultra-Low Dose IL-2 As Graft Versus Host Disease Prophylaxis in Haplo-Identical Stem Cell Transplantation- a Proof of Concept Pilot Study

Email alerts

ASH Publications

American Society of Hematology

Safe and Efficient Peripheral Blood Stem Cell Collection in Patients with Sickle Cell Disease Using Plerixafor

PD-1 Is Not a Reliable Marker of Impending Relapse after Allogeneic Stem Cell Transplantation

IFN-γ Induces Distinct Single Cell Transcriptomes in Clinical-Grade Mesenchymal Stromal Cells

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Safety and Feasibility of Ultra-Low Dose IL-2 As Graft Versus Host Disease Prophylaxis in Haplo-Identical Stem Cell Transplantation- a Proof of Concept Pilot Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only